OTCPK:GPHG

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Global Pharm Holdings Group

Executive Summary

Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Global Pharm Holdings Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GPHG has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

GPHG

-1.5%

US Healthcare

-3.1%

US Market


1 Year Return

n/a

GPHG

16.7%

US Healthcare

12.7%

US Market

Return vs Industry: Insufficient data to determine how GPHG performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how GPHG performed against the US Market.


Shareholder returns

GPHGIndustryMarket
7 Day0%-1.5%-3.1%
30 Day0%-5.4%-2.9%
90 Dayn/a1.5%8.2%
1 Yearn/a18.3%16.7%15.3%12.7%
3 Yearn/a26.0%20.5%37.8%28.5%
5 Yearn/a55.9%44.9%90.9%69.4%

Price Volatility Vs. Market

How volatile is Global Pharm Holdings Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Global Pharm Holdings Group undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Global Pharm Holdings Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Global Pharm Holdings Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Global Pharm Holdings Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Global Pharm Holdings Group regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Global Pharm Holdings Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Pharm Holdings Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Global Pharm Holdings Group performed over the past 5 years?

7.7%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Global Pharm Holdings Group has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

  • Examine Global Pharm Holdings Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Global Pharm Holdings Group's filings and announcements here.
  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is Global Pharm Holdings Group's financial position?


In this section we usually analyse Global Pharm Holdings Group's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Global Pharm Holdings Group has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of GPHG’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Global Pharm Holdings Group's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Global Pharm Holdings Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GPHG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GPHG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GPHG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GPHG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GPHG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.1yrs

Average management tenure


CEO

Yunlu Yin (53 yo)

10.08yrs

Tenure

US$30,000

Compensation

Mr. Yin Yunlu has been Chairman and Chief Executive Officer of Top Flight Game Birds, Inc. since August 6, 2010. Mr. Yunlu served as the Chief Executive Officer and President of BioPharm Asia Inc. from May ...


Leadership Team

NamePositionTenureCompensationOwnership
Yunlu Yin
Chairman and Chief Executive Officer10.08yrsUS$30.00kno data
Fu An
Chief Financial Officer and Director9.58yrsUS$569.55kno data
Dan Li
Vice President and Secretary10.08yrsUS$420.91kno data
Yanliang Song
Vice President In-Charge of Operations9.67yrsno datano data

10.1yrs

Average Tenure

50yo

Average Age

Experienced Management: GPHG's management team is seasoned and experienced (10.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yunlu Yin
Chairman and Chief Executive Officer10.08yrsUS$30.00kno data
Fu An
Chief Financial Officer and Director9.58yrsUS$569.55kno data
Kwong Wong
Non-Executive Director8.67yrsno datano data
Gene Bennett
Director9.58yrsno datano data

9.6yrs

Average Tenure

61yo

Average Age

Experienced Board: GPHG's board of directors are considered experienced (9.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Global Pharm Holdings Group, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Global Pharm Holdings Group, Inc.
  • Ticker: GPHG
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$36.910m
  • Shares outstanding: 37.28m
  • Website: https://www.globalpharmholdings.com

Location

  • Global Pharm Holdings Group, Inc.
  • Rongchao Tower
  • 29th Floor, Tower B
  • Shenzhen
  • Guangdong Province
  • 518026
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GPHGOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDAug 2010

Biography

Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in Chin ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/23 06:13
End of Day Share Price2020/08/06 00:00
Earnings2011/09/30
Annual Earnings2010/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.